本頁面由Tiger Trade Technology Pte. Ltd.提供服務

REIN THERAPEUTICS INC

0.7184
-0.0726-9.18%
成交量:35.27萬
成交額:26.17萬
市值:6,145.12萬
市盈率:-0.43
高:0.7900
開:0.7843
低:0.7175
收:0.7910
52周最高:2.18
52周最低:0.6940
股本:8,553.90萬
流通股本:6,583.01萬
量比:1.61
換手率:0.54%
股息:- -
股息率:- -
每股收益(TTM):-1.6800
每股收益(LYR):-1.9600
淨資產收益率:-96.42%
總資產收益率:-21.02%
市淨率:6.03
市盈率(LYR):-0.37

資料載入中...

2026/09/04

重要事件披露

Form 8-K - Current report
2026/08/28

重要事件披露

Form 8-K - Current report
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/21

重要事件披露

Form 8-K - Current report
2026/07/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/28

SEC問詢函

Form CORRESP - Correspondence
2026/04/28

SEC問詢函

Form CORRESP - Correspondence
2026/04/28

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/04/27

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/03/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/02

重要事件披露

Form 8-K - Current report